ACTIVE_NOT_RECRUITING

Sweet Scents to Sweet Dreams

Conditions

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this study is to determine the effect of herbal pillows on sleep and quality of life in a healthy population using actigraphy, validated questionnaires and daily diary logs. The goal of this study is to improve sleep and quality of life using herbal and Ayurveda/holistic-based botanical pillows.

Official Title

Sweet Scents to Sweet Dreams: Use of Herbal Pillows to Facilitate Sleep and Improve Quality of Life

Quick Facts

Study Start:2024-02-01

Study Completion:2026-02-01

Study Type:Not specified

Phase:Not Applicable

Enrollment:Not specified

Status:ACTIVE_NOT_RECRUITING

Study ID

NCT06247696

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years

Sexes Eligible for Study:ALL

Accepts Healthy Volunteers:Yes

Standard Ages:ADULT, OLDER_ADULT

Inclusion Criteria	Exclusion Criteria
* You must be at least 18 years of age. * You must be willing to adhere to a sleep hygiene protocol (e.g., 10pm-midnight-6-8am) for 2 weeks without interruption in the comfort of your home. * You must be willing to wear a watch that monitors your sleep and light as well as a sleep mask for two consecutive weeks. * During the testing period, you must be willing to refrain from alcohol and anything that can affect mood and sleep. * You must allow for the placement of an herbal pillow next to your head while sleeping for one week during testing. * You must be willing to fill out short sleep logs during the 2 weeks of testing. * You must also be willing to come to the study location on 3 occasions over a 2 week period.	* Males or females with any condition that prevents adequate inhalation of botanical pillows \[e.g., Chronic Obstructive Pulmonary Disease (COPD), use of a Continuous Positive Airway Pressure (CPAP), deviated septum, etc\]. * Males or females on mood altering substances prescription (e.g., anti-depressants, anxiolytics, Ritalin, Adderall, anti-convulsants; opioids, etc), non-prescription/over-the-counter (OTC) drugs/herbal/natural products \[(e.g., tetrahydrocannabinol (THC)-containing compounds, melatonin, St. John's Wort, lavender capsules, essential oils, perfume-containing products, etc\]. * Any environmental, physical condition or pathology that can significantly impact on sleep and prevent an approximate 10pm-midnight-6-8am sleep rhythm (e.g., shift work, studying/exams, rotations, insomnia, new parents, nocturia, restless leg syndrome, chronic pain, etc). * Any medications that can influence sleep \[(e.g., use of beta blockers; anti-histamines; dexamethasone; angiotensin converting enzyme inhibitor (ACEI); nicotine products, alpha blockers\] * Chemical sensitivities * Allergies * Pregnancy.

Inclusion Criteria

Exclusion Criteria

* You must be at least 18 years of age.
* You must be willing to adhere to a sleep hygiene protocol (e.g., 10pm-midnight-6-8am) for 2 weeks without interruption in the comfort of your home.
* You must be willing to wear a watch that monitors your sleep and light as well as a sleep mask for two consecutive weeks.
* During the testing period, you must be willing to refrain from alcohol and anything that can affect mood and sleep.
* You must allow for the placement of an herbal pillow next to your head while sleeping for one week during testing.
* You must be willing to fill out short sleep logs during the 2 weeks of testing.
* You must also be willing to come to the study location on 3 occasions over a 2 week period.

* Males or females with any condition that prevents adequate inhalation of botanical pillows \[e.g., Chronic Obstructive Pulmonary Disease (COPD), use of a Continuous Positive Airway Pressure (CPAP), deviated septum, etc\].
* Males or females on mood altering substances prescription (e.g., anti-depressants, anxiolytics, Ritalin, Adderall, anti-convulsants; opioids, etc), non-prescription/over-the-counter (OTC) drugs/herbal/natural products \[(e.g., tetrahydrocannabinol (THC)-containing compounds, melatonin, St. John's Wort, lavender capsules, essential oils, perfume-containing products, etc\].
* Any environmental, physical condition or pathology that can significantly impact on sleep and prevent an approximate 10pm-midnight-6-8am sleep rhythm (e.g., shift work, studying/exams, rotations, insomnia, new parents, nocturia, restless leg syndrome, chronic pain, etc).
* Any medications that can influence sleep \[(e.g., use of beta blockers; anti-histamines; dexamethasone; angiotensin converting enzyme inhibitor (ACEI); nicotine products, alpha blockers\]
* Chemical sensitivities
* Allergies
* Pregnancy.

Contacts and Locations

Principal Investigator

Paula A. Witt-Enderby

PRINCIPAL_INVESTIGATOR

Duquesne University

Study Locations (Sites)

Duquesne University

Pittsburgh, Pennsylvania, 15282

United States

Collaborators and Investigators

Sponsor: Duquesne University

Paula A. Witt-Enderby, PRINCIPAL_INVESTIGATOR, Duquesne University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-02-01

Study Completion Date2026-02-01

Study Record Updates

Study Start Date2024-02-01

Study Completion Date2026-02-01

Terms related to this study

Additional Relevant MeSH Terms

Sleep Disturbance
Mental Health Issue